Medical devices, healthcare technology and the business of care
510(k) clearance · K262618

Arthrex Spine Compression FT Screw

ARTHREX, INC. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK262618

What did the FDA decide?

FDA's 510(k) database records K262618 for the Arthrex Spine Compression FT Screw, submitted by Arthrex, Inc. of Naples, Florida, and received on 07/28/2026. The device is listed under classification product code MRW, with HWC as a subsequent product code, and the review panel is recorded as Orthopedic. The record describes the submission type as Traditional, with no third-party review, no combination product status and no authorized predetermined change control plan.

FDA recorded a decision of Substantially Equivalent (SESE) on 09/24/2026, meaning the submission was cleared as a 510(k) rather than approved through the PMA pathway. The record does not identify a predicate device, summarize the technological comparison, or describe the specific screw components or indications for use; the specialty field is listed as Unknown. The public page was last updated 09/28/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Sep 24, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262618
Regulatory pathway
510(k) premarket notification
Applicant
ARTHREX, INC.
Product code
MRW
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Facet Screw Spinal Device.

Applicant
Arthrex, Inc.
Product code
MRW
FDA device class
U

FDA decision timeline

  1. K262618 received

    Application receipt date recorded by FDA.

  2. K262618 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arthrex, Inc.

Headquarters
Not reported
Brand website
arthrex.com
FDA applicant address
Naples, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records